Project Details
Description
Drs. Miller and Luo will interact with the other investigators in designing experiments, interpreting results, and writing progress reports and manuscripts. The experiments will be performed testing immune-modifying nanoparticles previously developed by Dr. Miller and his collaborators and SA-FasL chimeric proteins.
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/15 → 3/31/16 |
Funding
- University of Wisconsin-Madison (623K976 // U01AI102456)
- National Institute of Allergy and Infectious Diseases (623K976 // U01AI102456)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.